title: Different intracellular signalling pathways triggered by an anti-prolactin receptor (PRLR) antibody: Implication for a signal-specific PRLR agonist.
abstract: In this work, we prepared a panel of monoclonal antibodies directed against prolactin receptor (PRLR) using the hybridoma technique. Of these monoclonal antibodies (Mabs), the Mab designated B6 was chosen for further characterization based on its biological activity. We first demonstrated that B6 can specifically bind to the prolactin receptor (PRLR) expressed on target cells by immunoprecipitation and Western blotting analysis. Subsequently, epitope mapping studies using a competitive receptor-binding assay indicated that B6 epitopes partially overlapped with those of prolactin (PRL). We then examined the resulting signal transduction pathways activated by this antibody in T-47D and CHO-PRLR cells and found that B6 induced different intracellular signalling compared with prolactin, which activates serine-threonine kinase (AKT), extracellular signal-regulated kinase 1/2 (ERK1/2), signal transducer and activator of transcription1 (STAT1) and STAT3 but not STAT5. The present study suggests that: (a) B6 may be a signal-specific prolactin receptor (PRLR) agonist; (b) B6 may be a biological reagent that can be used to explore the mechanism of PRLR-mediated intracellular signalling. In addition, this work also implies a strategy for preparing signal-specific cytokine agonists.
authors.affiliation: Department of Endocrinology, Henan Provincial People's Hospital, Zhengzhou 450003, China. Electronic address: kanquane2015@163.com.
authors.forename: Quan-E
authors.initials: QE
authors.lastname: Kan
authors.affiliation: Department of Endocrinology, Henan Provincial People's Hospital, Zhengzhou 450003, China.
authors.forename: Yong
authors.initials: Y
authors.lastname: Su
authors.affiliation: Department of Endocrinology, Henan Provincial People's Hospital, Zhengzhou 450003, China.
authors.forename: Huihui
authors.initials: H
authors.lastname: Yang
authors.affiliation: Department of Endocrinology, Henan Provincial People's Hospital, Zhengzhou 450003, China.
authors.forename: Hua
authors.initials: H
authors.lastname: Man
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis / Q000276:immunology / Q000378:metabolism / Q000494:pharmacology*; D016466:CHO Cells; D045744:Cell Line, Tumor; D003412:Cricetulus; D000939:Epitopes / Q000276:immunology / Q000378:metabolism; D005260:Female; D006801:Humans; D042541:Intracellular Space / Q000378:metabolism; D053614:Janus Kinase 2 / Q000378:metabolism; D051379:Mice; D011485:Protein Binding; D011981:Receptors, Prolactin / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects*
chemical_list: D000911:Antibodies, Monoclonal; D000939:Epitopes; D011981:Receptors, Prolactin; D053614:Janus Kinase 2
keywords: Anti-PRLR antibody; Prolactin; Signal transduction